Millions of Americans use GLP-1 injections like Ozempic to lose weight. A study is questioning whether they can cause vision loss.

Now, one type of weight-loss medication is proving helpful with another health issue. In a study published Feb. 12 in JAMA Psychiatry, researchers report that semaglutide, better known as Ozempic or Wegovy, helped people with alcohol addiction reduce their craving and drink less.

The General Pharmaceutical Council (GPhC) have published the new guidance for prescribing weight loss injections such as Wegovy or Mounjaro online, which includes stricter checks to verify the patient is eligible.

Health experts are investigating a possible link between popular weight loss drugs like Ozempic and sudden blindness.

Some users experience side-effects such as nausea, diarrhoea and fatigue. Other clinical studies have found that some patients taking weight-loss drugs lose muscle at far faster rates than those relying on diet or exercise.

GLP-1) receptor agonists, which are used to treat type 2 diabetes and/or obesity, were linked to vision problems in a small study. Here's what doctors have to say.